Risk of clinically significant depression in HIV‐infected patients: effect of antiretroviral drugs

Authors:

Abstract
Objectives: We aimed to characterize depression in newly diagnosed HIV‐infected patients, to determine the effect of antiretroviral therapy (ART) on its incidence, and to investigate whether efavirenz use was associated with a higher risk, compared with non‐efavirenz‐containing regimens, in the Spanish CoRIS cohort.Methods: CoRIS is a contemporary, multicentre cohort of HIV‐infected patients, antiretroviral‐naïve at entry, launched in 2004. Poisson regression models were used to investigate demographic, clinical and treatment‐related factors associated with a higher incidence of clinically significant depression to October 2010.Results: In total, 5185 patients (13 089 person‐years) participated in the study, of whom 3379 (65.2%) started ART during follow‐up. The incidence rates of depression before and after starting ART were 11.68 [95% confidence interval (CI) 9.01–15.15] and 7.06 (95% CI 5.45–9.13) cases per 1000 person‐years, respectively. After adjustment, there was an inverse association between the occurrence of depression and the initiation of ART [incidence rate ratio (IRR) 0.53; 95% CI 0.28–0.99], while the likelihood of depression increased in patients of age > 50 years (IRR 1.94; 95% CI 1.21–3.12). Longer exposure to ART was associated with a decreased IRR of depression in unadjusted and adjusted analyses. The IRR for patients receiving < 2, 2–4 and > 4 years of ART was 0.72 (95% CI 0.36–1.44), 0.10 (95% CI 0.04–0.25) and 0.05 (95% CI 0.01–0.17), respectively, compared with ART‐naïve patients. This protective effect was also observed when durations of exposure to nonnucleoside reverse transcriptase inhibitor‐based regimens and efavirenz‐containing regimens were analysed separately.Conclusions: The incidence of clinically significant depression was lower among HIV‐infected patients on ART. The protective effect of ART was also observed with efavirenz‐containing regimens.
Funding Information
  • Red Tem�tica de Investigaci�n Cooperativa en VIH/SIDA-ISC III-RETIC, and Instituto de Salud Carlos III-FIS, Spanish Ministry of Health (RD06/0027-RD12/0017-PI081893)

This publication has 34 references indexed in Scilit: